Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NALVANCA: Immune Monitoring Following B-cell Depletion in ANCA-associated Vasculitis

NCT07636655 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07636655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NALVANCA: Immune Monitoring Following B-cell Depletion in ANCA-associated Vasculitis
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2051
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vasculitis associated with anti-neutrophil cytoplasmic antibodies